DE69528379T2 - Paraoxonase aus serum - Google Patents

Paraoxonase aus serum

Info

Publication number
DE69528379T2
DE69528379T2 DE69528379T DE69528379T DE69528379T2 DE 69528379 T2 DE69528379 T2 DE 69528379T2 DE 69528379 T DE69528379 T DE 69528379T DE 69528379 T DE69528379 T DE 69528379T DE 69528379 T2 DE69528379 T2 DE 69528379T2
Authority
DE
Germany
Prior art keywords
serum paraoxonase
polypeptide
disclosed
present
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69528379T
Other languages
English (en)
Other versions
DE69528379D1 (de
Inventor
Peter L Hudson
Wei Wu He
Steven M Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Application granted granted Critical
Publication of DE69528379D1 publication Critical patent/DE69528379D1/de
Publication of DE69528379T2 publication Critical patent/DE69528379T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE69528379T 1994-07-05 1995-06-28 Paraoxonase aus serum Expired - Fee Related DE69528379T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/270,583 US5629193A (en) 1994-07-05 1994-07-05 Paraoxonase
PCT/US1995/008111 WO1996001322A1 (en) 1994-07-05 1995-06-28 Serum paraoxonase

Publications (2)

Publication Number Publication Date
DE69528379D1 DE69528379D1 (de) 2002-10-31
DE69528379T2 true DE69528379T2 (de) 2003-06-12

Family

ID=23031914

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528379T Expired - Fee Related DE69528379T2 (de) 1994-07-05 1995-06-28 Paraoxonase aus serum

Country Status (13)

Country Link
US (4) US5629193A (de)
EP (2) EP1217007A2 (de)
JP (2) JPH10502255A (de)
KR (1) KR970704887A (de)
CN (1) CN1151760A (de)
AT (1) ATE224953T1 (de)
CA (1) CA2194390A1 (de)
DE (1) DE69528379T2 (de)
DK (1) DK0804591T3 (de)
ES (1) ES2180648T3 (de)
NZ (1) NZ289607A (de)
PT (1) PT804591E (de)
WO (1) WO1996001322A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629193A (en) 1994-07-05 1997-05-13 Human Genome Sciences, Inc. Paraoxonase
GB9511412D0 (en) * 1995-06-06 1995-08-02 Johnson Matthey Plc Improvements in emission control
US7541519B2 (en) * 1995-12-14 2009-06-02 Cargill, Incorporated Fatty acid desaturases and mutant sequences thereof
ATE260931T1 (de) * 1997-06-30 2004-03-15 Glaxo Group Ltd Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
US6414223B1 (en) 1998-08-03 2002-07-02 Cargill, Incorporated Plants, seeds and oils having an elevated total monounsaturated fatty acid content
US6391298B1 (en) * 1998-11-25 2002-05-21 Bayer Corporation Method of using PON-1 to decrease atheroma formation
JP2000333674A (ja) * 1999-05-24 2000-12-05 Bml Inc パラオキソナーゼに対するモノクローナル抗体及びこれを用いる動脈硬化の判定方法
US6573370B1 (en) * 2000-05-19 2003-06-03 Regents Of The University Of Michigan PON3 and uses thereof
US20020151068A1 (en) * 2001-01-03 2002-10-17 Board Of Regents, The University Of Texas System Compositions and methods for the diagnosis and treatment of organophosphate toxicity
CN1854300B (zh) * 2005-04-29 2013-04-17 中国人民解放军军事医学科学院毒物药物研究所 含pon基因的重组质粒及其应用
SG178773A1 (en) * 2006-11-13 2012-03-29 Ateris Technologies Llc Pesticide biomarker
US20110166043A1 (en) * 2007-11-14 2011-07-07 Jon Owen Nagy Biomarker detection-2
US20130071394A1 (en) 2011-09-16 2013-03-21 John K. Troyer Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use
CN108196064A (zh) * 2017-12-26 2018-06-22 黑龙江八农垦大学 一种牛pon1蛋白的双抗夹心elisa检测试剂盒及检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5260203A (en) * 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5629193A (en) 1994-07-05 1997-05-13 Human Genome Sciences, Inc. Paraoxonase

Also Published As

Publication number Publication date
NZ289607A (en) 1998-11-25
AU2950795A (en) 1996-01-25
DK0804591T3 (da) 2003-01-20
JP2003088364A (ja) 2003-03-25
US7026140B2 (en) 2006-04-11
US20050026226A1 (en) 2005-02-03
EP0804591A4 (de) 1998-07-29
CN1151760A (zh) 1997-06-11
EP0804591A1 (de) 1997-11-05
EP0804591B1 (de) 2002-09-25
ATE224953T1 (de) 2002-10-15
ES2180648T3 (es) 2003-02-16
US5629193A (en) 1997-05-13
US5792639A (en) 1998-08-11
EP1217007A2 (de) 2002-06-26
KR970704887A (ko) 1997-09-06
AU704834B2 (en) 1999-05-06
PT804591E (pt) 2002-12-31
DE69528379D1 (de) 2002-10-31
US6140093A (en) 2000-10-31
JPH10502255A (ja) 1998-03-03
WO1996001322A1 (en) 1996-01-18
CA2194390A1 (en) 1996-01-18

Similar Documents

Publication Publication Date Title
DE69528379D1 (de) Paraoxonase aus serum
ATE310819T1 (de) Säugetieren apoptosis inhibitorprotein genfamilie,primers, probes und verfahren zur nachweis
Summaria et al. Isolation and characterization of the affinity chromatography forms of human Glu-and Lys-plasminogens and plasmins.
DE69635864D1 (de) Rekombinante rna-replikase von hepatitis-c-virus
CY1107629T1 (el) Πρωτεïνη crsp (πλουσιες σε κυστεïνη εκκρινομενες πρωτεïνες) μορια νουκλεϊνικου οξεως που τις κωδικοποιουν και χρησεις τους
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
AU7019498A (en) Pca3, pca3 genes, and methods of use
Rodriguez et al. Modification of the C-terminus of brain tubulin during development
ATE523593T1 (de) Membranproteine aus säugetierzellen und verwandte reagentien
ATE79403T1 (de) Herstellung von thrombin-inhibitoren.
DE69808743T2 (de) Netrinrezeptoren
WO1999025878A3 (en) Methods for modulating and identifying cellular senescence
WO2000020446A3 (en) Bax-mediated apoptosis modulating reagents and methods
DK0750626T3 (da) Stannius-korpuskel-protein, stanniocalcin
ATE321888T1 (de) Sonden zur erkennung und identifizierung von helicobacter pylori
MX9700149A (es) Seroparaoxonasa.
JPS6467197A (en) Enzymatically inactive and immunologically active b-galatosidase-mutagenic protein, its preparation, immulogical assay of serum protein, and enzyme-immunoassay reagent
WO1997035976A3 (en) Epidermal differentiation factor
Boschetti et al. The membrane anchor of mammalian brain acetylcholinesterase consists of a single glycosylated protein of 22 kDa
EP0841399A3 (de) Menschliche Fin-1 Nukleinsäure (eine Caspase) und Proteinsequenzen und Verwendung davon
Finel Studies on the oligomeric state of isolated cytochrome oxidase using cross-linking reagents
WO2003044170A3 (en) Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
Oppenheim et al. A modified procedure for the purification of clostridial collagenase
NO971359L (no) Humant galaktokinase-gen
Kurosawa et al. Classification of mouse submaxillary gland esteroproteases by their substrate specificities

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee